newsfilter
← Latest News
PR Newswire·

BiondVax provides plan to address Nasdaq compliance

JERUSALEM, Nov. 2, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) ("BiondVax"), a biotechnology company focused on developing, manufacturing, and commercializing innovative products for the